CARUSO RICHARD E 4
4 · INTEGRA LIFESCIENCES HOLDINGS CORP · Filed Apr 24, 2020
Insider Transaction Report
Form 4
CARUSO RICHARD E
Director10% Owner
Transactions
- Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2020-04-22−13,876→ 0 totalExercise: $14.64Exp: 2020-05-17→ Common Stock (13,876 underlying) - Exercise/Conversion
Common Stock
2020-04-22$14.64/sh+15,658$229,311→ 149,792 total - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2020-04-22−15,658→ 13,876 totalExercise: $14.64Exp: 2020-05-17→ Common Stock (15,658 underlying) - Exercise/Conversion
Common Stock
2020-04-22$14.64/sh+13,876$203,214→ 163,668 total
Holdings
- 10,891,205(indirect: By Partnership)
Common Stock
- 4,000(indirect: By Son)
Common Stock
Footnotes (4)
- [F1]25% of the stock options vest every quarter from the grant date of 5/17/2012
- [F2]This option was previously reported as covering 7,500 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $29.29 per share.
- [F3]In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
- [F4]This option was previously reported as covering 6,647 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,938 shares of common stock at an exercise price of $29.29 per share.